FindTrial
Sign In

Comparison of the effect of two balanced crystalloid intraoperative (iv) solutions ( plasmalyte vs sterofundin) on lactate levels during major cancer surgeries.

Comparison of the effect of intraoperative fluids (plasmalyte vs sterofundin) during major oncological surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028716
Enrollment
60
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D099- Carcinoma in situ, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Plasma Lyte A: Imported and marketed in India by Baxter India Pvt Ltd Will be given intravenously Frequency and dosing will be PVI regulated Duration will be the intra-operative perio

Sponsors

Rajiv Gandhi cancer institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing major onco-surgeries.

Exclusion criteria

Exclusion criteria: patients with significant renal, cardiac, or liver impairment, electrolyte imbalance in preoperative evaluation.

Design outcomes

Primary

MeasureTime frame
pH and lactate levels in ABGTimepoint: At the start of surgery and at the time of haemostasis—

Secondary

MeasureTime frame
Heart rate, mean blood pressure, total amount of crystalloid required, colloid requirement, blood replaced,Timepoint: Baseline, hourly intraoperatively till end of surgery—

Countries

India

Contacts

Public Contactdeepti gupta

Rajiv Gandhi cancer institute and research centre Rohini

mamcdeepti@gmail.com7065840893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026